NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Evaluation of Clinical, Morphologic and Biochemical Markers in Multiple Sclerosis
Evaluation of Clinical, Morphologic and Biochemical Markers in Multiple Sclerosis
UnknownN/A
Sponsor: Medical University of Graz
Conditions: Multiple Sclerosis
Interventions: blood sample
Countries: Austria
By combining clinical, morphological and biochemical markers a better understanding of the formation and progression of multiple sclerosis (MS) should be obtained
Eligibility overview
Sex: ALL
Age: 18 Years to 85 Years
Healthy volunteers: Yes
Study type: OBSERVATIONAL
Eligibility criteria
Inclusion Criteria: * Patients with suspected or proven multiple sclerosis * The participants are patients who are in inpatient or outpatient care of the Department of Neurology at the Medical University of Graz, Austria Exclusion Criteria: * Excluded from the examinations are all patients for whom an MRI examination is impossible or problematic
Locations (1)
- Graz, Styria, Austria